The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 30, 2025
Filed:
Feb. 12, 2021
Applicant:
Vertex Pharmaceuticals Incorporated, Boston, MA (US);
Inventor:
Marinus Jacobus Verwijs, Framingham, MA (US);
Assignee:
Vertex Pharmaceuticals Incorporated, Boston, MA (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/28 (2006.01); A61J 3/10 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 31/443 (2006.01); A61K 31/47 (2006.01); A61K 31/4709 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/28 (2013.01); A61J 3/10 (2013.01); A61K 9/1623 (2013.01); A61K 9/1652 (2013.01); A61K 9/2054 (2013.01); A61K 9/2077 (2013.01); A61K 9/2866 (2013.01); A61K 31/443 (2013.01); A61K 31/47 (2013.01); A61K 31/4709 (2013.01); A61K 45/06 (2013.01);
Abstract
A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a disintegrant, a surfactant, a binder, and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Processes of preparing pharmaceutical compositions comprising Compound 1 are also disclosed.